Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:22 AM
Ignite Modification Date:
2025-12-25 @ 1:22 AM
NCT ID:
NCT02933593
Eligibility Criteria:
Inclusion Criteria:
* Pregnant women
* Singleton pregnancy
* Severe hypertension as defined by a blood pressure of 160/110 with plans to treat
Exclusion Criteria:
* Multiple pregnancy
* Blood pressures \< 160/110, or those whose blood pressures do not require medication for control
* Irregular heart rhythms or arrhythmias
* Peripheral arterial disease, leg artery disease
* Reynaud's phenomena
* Intense cold/hypothermia
* If there is a wound at location of where central arterial cuff would be placed or tonometer for carotid assessment
* Known sensitivity to labetalol, nifedipine, or hydralazine
* Severe tachycardia (\>120)
* Greater than 1st degree heart block
* Severe asthma
* Congestive heart failure or heart disease
* Lupus
* Inability to adequately monitor BP
* Inability to monitor fetus (if 23 weeks or above)
* Magnesium started prior to initiation of study
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
14 Years
Maximum Age:
50 Years
Study:
NCT02933593
Study Brief:
Protocol Section:
NCT02933593